Patient preference study of once-monthly ibandronate versus once-weekly alendronate

被引:0
|
作者
Emkey, R
Binkley, N
Seidman, L
Rosen, C
机构
[1] Reading Hosp, Reading, PA USA
[2] Univ Wisconsin, Madison, WI 53706 USA
[3] Philadelphia Womens Res, Philadelphia, PA USA
[4] St Joseph Hosp, Bangor, ME 04401 USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:797 / 797
页数:1
相关论文
共 50 条
  • [31] Rapid suppression of serum CTX with once-monthly oral ibandronate
    Adami, S.
    Boisdron, J.
    Silverman, S.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S211 - S211
  • [32] Patient preferences with a once-monthly bisphosphonate
    Dore, R. K.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S258 - S258
  • [33] ONCE-MONTHLY ORAL IBANDRONATE A NEW BISPHOSPHONATE DOSING CONCEPT
    Reginster, J.
    Miller, P.
    Delmas, P.
    Lorenc, R.
    Stakkestad, J.
    Christiansen, C.
    Wiese, C.
    Wilson, K.
    Coutant, K.
    Bonvoisin, B.
    Dumont, E.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S85 - S85
  • [34] A novel bisphosphonate dosing regimen: Once-monthly oral ibandronate
    Cooper, C
    Adami, S
    Stepan, JJ
    Wiese, C
    Wilson, K
    Coutant, K
    Dumont, E
    Reginster, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 452 - 453
  • [35] Once-weekly alendronate has superior antiresorptive efficacy and comparable upper gastrointestinal tolerability to once-weekly risedronate
    Hochberg, M
    Rosen, C
    Bonnick, S
    Saag, K
    Broy, S
    McClung, GI
    Chen, E
    Petruschke, RA
    de Papy, AE
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S292 - S293
  • [36] Once-weekly alendronate: Subgroup efficacy analyses.
    Bone, H
    Roux, C
    Schnitzer, T
    Smith, I
    Insogna, K
    Miller, P
    Santora, A
    Kaur, A
    Yates, J
    Orloff, J
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2001, 10 (04): : 404 - 404
  • [37] Once-weekly alendronate: Subgroup efficacy analyses.
    Bone, H
    Roux, C
    Schnitzer, T
    Smith, I
    Insogna, KL
    Miller, P
    Santora, A
    Kaur, A
    Yates, J
    Orloff, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S197 - S197
  • [38] Once-weekly alendronate: Upper GI safety profile
    Schnitzer, T
    Emkey, R
    Smith, I
    Foldes, J
    Ettinger, M
    Reid, I
    Orloff, J
    Santora, A
    Kaur, A
    Freedholm, D
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S199 - S199
  • [39] Patient perspectives on once-weekly fluoxetine
    Judge, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 53 - 57
  • [40] Better clinical response for once-monthly compared with daily oral ibandronate
    Sunyecz, J
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 108S - 108S